AIChE will undertake a routine upgrade of our digital infrastructure between 12AM to 6AM ET on Tuesday April 22. During this time access to all services that require login or payment will be unavailable.
This SBE supplement covers the development of continuous processing techniques in upstream and downstream biopharmaceutical processes. It also details factors that are impeding end-to-end implementation of continuous biopharmaceutical manufacturing processes, and points out that despite some misconceptions, regulators such as the U.S. Food and Drug Administration (FDA), encourage, rather than prevent, continuous processing. Other topics in this issue include cyclic ditillation and France's chemical industry.
